{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:15:16Z","timestamp":1765527316161,"version":"3.48.0"},"reference-count":28,"publisher":"Walter de Gruyter GmbH","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_hmbci-2019-0058_s_999_w2aab3b7c36b1b6b1aab1c14b1Aa\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The aim of this study was to analyze two different polymorphisms, Ser680Asn and -29 (G&gt;A) promoter polymorphism, of the follicle-stimulating hormone receptor (\n                      <jats:italic>FSHR<\/jats:italic>\n                      ) gene, individually but also in combination, in a sample of Greek women undergoing in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2019-0058_s_998_w2aab3b7c36b1b6b1aab1c14b2Aa\">\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>One hundred and forty-one women undergoing IVF or ICSI and 94 controls were genotyped by real-time polymerase chain reaction (RT-PCR) for the two FSHR polymorphisms. The association of the alleles with the clinical, biochemical and other parameters concerning the controlled ovarian stimulation (COS) protocol and outcome was investigated, as well as the pregnancy rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2019-0058_s_997_w2aab3b7c36b1b6b1aab1c14b3Aa\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study of each polymorphism individually revealed a positive correlation of the SerSer genotype (Ser680Asn polymorphism) with higher luteinizing hormone (LH) levels on the third day of the menstrual cycle. On the other hand, the A allele for the -29 (G&gt;A) promoter polymorphism correlated with the increased number and quality of cumulus-oocyte complexes (COCs). No differences were detected when the different genotypes of the two polymorphisms were combined \u2013 the population study was grouped according to the number of polymorphic alleles they carried (0\u20134 alleles). Women who presented all polymorphic alleles, AsnAsn\/AA, exhibited the lowest LH levels (2.62 \u00b1 0.68 mIU\/L), but were rarely detected (n = 2, 1.4% of the studied population).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_hmbci-2019-0058_s_996_w2aab3b7c36b1b6b1aab1c14b4Aa\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The data from this study reflect that the investigation of the combination of polymorphisms, such as FSHR -29 and Ser680Asn, could offer a valuable tool in order to evaluate and anticipate the outcome of the ovulation induction protocols, especially in the group of patients with failed attempts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/hmbci-2019-0058","type":"journal-article","created":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T04:01:46Z","timestamp":1583035306000},"source":"Crossref","is-referenced-by-count":9,"title":["The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF\/ICSI"],"prefix":"10.1515","volume":"41","author":[{"given":"Chrysa","family":"Paschalidou","sequence":"first","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elli","family":"Anagnostou","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Despoina","family":"Mavrogianni","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rami","family":"Raouasnte","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikiforos","family":"Klimis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Drakakis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , Athens , Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Loutradis","sequence":"additional","affiliation":[{"name":"1st Department of Obstetrics and Gynecology, Division of Human Reproduction, IVF Unit, Alexandra Hospital , Medical School of National Kapodistrian University of Athens , 62 Sirinon Str , Athens 17562, P. Faliro , Greece , Phone: 0030 210 9833576"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2020,3,2]]},"reference":[{"doi-asserted-by":"crossref","unstructured":"Gearhart J, Coutifaris C. In vitro fertilization, the Nobel Prize, and human embryonic stem cells. Cell Stem Cell. 2011;8:12\u20135.","key":"2025121207192862510_j_hmbci-2019-0058_ref_001_w2aab3b7c36b1b6b1ab2b1b1Aa","DOI":"10.1016\/j.stem.2010.12.015"},{"doi-asserted-by":"crossref","unstructured":"George JW, Dille EA, Heckert LL. Current concepts of follicle-stimulating hormone receptor gene regulation. Biol Reprod. 2011;84:7\u201317.","key":"2025121207192862510_j_hmbci-2019-0058_ref_002_w2aab3b7c36b1b6b1ab2b1b2Aa","DOI":"10.1095\/biolreprod.110.085043"},{"doi-asserted-by":"crossref","unstructured":"Gromoll J, Simoni M. Genetic complexity of FSH receptor function. Trends Endocrinol Metab. 2005;16:368\u201373.","key":"2025121207192862510_j_hmbci-2019-0058_ref_003_w2aab3b7c36b1b6b1ab2b1b3Aa","DOI":"10.1016\/j.tem.2005.05.011"},{"doi-asserted-by":"crossref","unstructured":"Simoni M, Casarini L. Mechanisms in endocrinology: genetics of FSH action: a 2014-and-beyond view. Eur J Endocrinol. 2014;170:R91\u2013107.","key":"2025121207192862510_j_hmbci-2019-0058_ref_004_w2aab3b7c36b1b6b1ab2b1b4Aa","DOI":"10.1530\/EJE-13-0624"},{"doi-asserted-by":"crossref","unstructured":"Perez Mayorga M, Gromoll J, Behre HM, Gassner C, Nieschlag E, Simoni M. Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab. 2000;85:3365\u20139.","key":"2025121207192862510_j_hmbci-2019-0058_ref_005_w2aab3b7c36b1b6b1ab2b1b5Aa","DOI":"10.1210\/jcem.85.9.6789"},{"doi-asserted-by":"crossref","unstructured":"Casarini L, Moriondo V, Marino M, Adversi F, Capodanno F, Grisolia C, et al. FSHR polymorphism p.N680S mediates different responses to FSH in vitro. Mol Cell Endocrinol. 2014;393:83\u201391.","key":"2025121207192862510_j_hmbci-2019-0058_ref_006_w2aab3b7c36b1b6b1ab2b1b6Aa","DOI":"10.1016\/j.mce.2014.06.013"},{"doi-asserted-by":"crossref","unstructured":"de Castro F, Mor\u00f3n FJ, Montoro L, Gal\u00e1n JJ, Hern\u00e1ndez DP, Padilla ES, et al. Human controlled ovarian hyperstimulation outcome is a polygenic trait. Pharmacogenetics. 2004;14:285\u201393.","key":"2025121207192862510_j_hmbci-2019-0058_ref_007_w2aab3b7c36b1b6b1ab2b1b7Aa","DOI":"10.1097\/00008571-200405000-00003"},{"doi-asserted-by":"crossref","unstructured":"Loutradis D, Patsoula E, Minas V, Koussidis GA, Antsaklis A, Michalas S, et al. FSH receptor gene polymorphisms have a role for different ovarian response to stimulation in patients entering IVF\/ICSI-ET programs. J Assist Reprod Genet. 2006;23:177\u201384.","key":"2025121207192862510_j_hmbci-2019-0058_ref_008_w2aab3b7c36b1b6b1ab2b1b8Aa","DOI":"10.1007\/s10815-005-9015-z"},{"doi-asserted-by":"crossref","unstructured":"Livshyts G, Podlesnaja S, Kravchenko S, Sudoma I, Livshits L. A distribution of two SNPs in exon 10 of the FSHR gene among the women with a diminished ovarian reserve in Ukraine. J Assist Reprod Genet. 2009;26:29\u201334.","key":"2025121207192862510_j_hmbci-2019-0058_ref_009_w2aab3b7c36b1b6b1ab2b1b9Aa","DOI":"10.1007\/s10815-008-9279-1"},{"doi-asserted-by":"crossref","unstructured":"Wunsch A, Ahda Y, Banaz-Ya\u015far F, Sonntag B, Nieschlag E, Simoni M, et al. Single-nucleotide polymorphisms in the promoter region influence the expression of the human follicle-stimulating hormone receptor. Fertil Steril. 2005;84:446\u201353.","key":"2025121207192862510_j_hmbci-2019-0058_ref_010_w2aab3b7c36b1b6b1ab2b1c10Aa","DOI":"10.1016\/j.fertnstert.2005.02.031"},{"doi-asserted-by":"crossref","unstructured":"Desai SS, Achrekar SK, Paranjape SR, Desai SK, Mangoli VS, Mahale SD. Association of allelic combinations of FSHR gene polymorphisms with ovarian response. Reprod Biomed Online. 2013;27:400\u20136.","key":"2025121207192862510_j_hmbci-2019-0058_ref_011_w2aab3b7c36b1b6b1ab2b1c11Aa","DOI":"10.1016\/j.rbmo.2013.07.007"},{"doi-asserted-by":"crossref","unstructured":"Desai SS, Achrekar SK, Pathak BR, Desai SK, Mangoli VS, Mangoli RV, et al. Follicle-stimulating hormone receptor polymorphism (G-29A) is associated with altered level of receptor expression in Granulosa cells. J Clin Endocrinol Metab. 2011;96:2805\u201312.","key":"2025121207192862510_j_hmbci-2019-0058_ref_012_w2aab3b7c36b1b6b1ab2b1c12Aa","DOI":"10.1210\/jc.2011-1064"},{"doi-asserted-by":"crossref","unstructured":"Borgbo T, Klu\u010dkov\u00e1 H, Macek M Sr, Chrudimska J, Kristensen SG, Hansen LL, et al. The common follicle-stimulating hormone receptor (FSHR) promoter polymorphism FSHR -29G > A affects androgen production in normal human small antral follicles. Front Endocrinol (Lausanne). 2017;8:122.","key":"2025121207192862510_j_hmbci-2019-0058_ref_013_w2aab3b7c36b1b6b1ab2b1c13Aa","DOI":"10.3389\/fendo.2017.00122"},{"doi-asserted-by":"crossref","unstructured":"Loutradis D, Drakakis P, Kallianidis K, Milingos S, Dendrinos S, Michalas S. Oocyte morphology correlates with embryo quality and pregnancy rate after intracytoplasmic sperm injection. Fertil Steril. 1999;72:240\u20134.","key":"2025121207192862510_j_hmbci-2019-0058_ref_014_w2aab3b7c36b1b6b1ab2b1c14Aa","DOI":"10.1016\/S0015-0282(99)00233-2"},{"doi-asserted-by":"crossref","unstructured":"Loutradis D, Drakakis P, Milingos S, Stefanidis K, Michalas S. Alternative approaches in the management of poor response in controlled ovarian hyperstimulation (COH). Ann N Y Acad Sci. 2003;997:112\u20139.","key":"2025121207192862510_j_hmbci-2019-0058_ref_015_w2aab3b7c36b1b6b1ab2b1c15Aa","DOI":"10.1196\/annals.1290.013"},{"doi-asserted-by":"crossref","unstructured":"Lindgren I, B\u00e5\u00e5th M, Uvebrant K, Dejmek A, Kjaer L, Henic E, et al. Combined assessment of polymorphisms in the LHCGR and FSHR genes predict chance of pregnancy after in vitro fertilization. Hum Reprod. 2016;31:672\u201383.","key":"2025121207192862510_j_hmbci-2019-0058_ref_016_w2aab3b7c36b1b6b1ab2b1c16Aa","DOI":"10.1093\/humrep\/dev342"},{"doi-asserted-by":"crossref","unstructured":"Lledo B, Dapena P, Ortiz JA, Morales R, Llacer J, Bernabeu R. Clinical efficacy of recombinant versus highly purified follicle-stimulating hormone according to follicle-stimulating hormone receptor genotype. Pharmacogenet Genomics. 2016;26:288\u201393.","key":"2025121207192862510_j_hmbci-2019-0058_ref_017_w2aab3b7c36b1b6b1ab2b1c17Aa","DOI":"10.1097\/FPC.0000000000000215"},{"unstructured":"Fleming R, Durnerin IC, Erb K, Hillier SG, Hugues JN, Lyall H. Pre-treatment with rhLH: respective effects on antral follicular count and ovarian response to rhFSH. Hum Reprod. 2006;21:i54.","key":"2025121207192862510_j_hmbci-2019-0058_ref_018_w2aab3b7c36b1b6b1ab2b1c18Aa"},{"doi-asserted-by":"crossref","unstructured":"Papamentzelopoulou M, Mavrogianni D, Partsinevelos GA, Marinopoulos S, Dinopoulou V, Theofanakis C, et al. LH receptor gene expression in cumulus cells in women entering an ART program. J Assist Reprod Genet. 2012;29:409\u2013416.","key":"2025121207192862510_j_hmbci-2019-0058_ref_019_w2aab3b7c36b1b6b1ab2b1c19Aa","DOI":"10.1007\/s10815-012-9729-7"},{"doi-asserted-by":"crossref","unstructured":"Alviggi C, Clarizia R, Pettersson K, Mollo A, Humaidan P, Strina I, et al. Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism. Reprod Biomed Online. 2009;18:9\u201314.","key":"2025121207192862510_j_hmbci-2019-0058_ref_020_w2aab3b7c36b1b6b1ab2b1c20Aa","DOI":"10.1016\/S1472-6483(10)60418-X"},{"doi-asserted-by":"crossref","unstructured":"Anagnostou E, Mavrogianni D, Theofanakis C, Drakakis P, Bletsa R, Demirol A, et al. ESR1, ESR2 and FSH receptor gene polymorphisms in combination: a useful genetic tool for the prediction of poor responders. Curr Pharm Biotechnol. 2012;13:426\u201334.","key":"2025121207192862510_j_hmbci-2019-0058_ref_021_w2aab3b7c36b1b6b1ab2b1c21Aa","DOI":"10.2174\/138920112799361891"},{"doi-asserted-by":"crossref","unstructured":"Behre HM, Greb RR, Mempel A, Sonntag B, Kiesel L, Kaltwasser P, et al. Significance of a common single nucleotide polymorphism in exon 10 of the follicle-stimulating hormone (FSH) receptor gene for the ovarian response to FSH: a pharmacogenetic approach to controlled ovarian hyperstimulation. Pharmacogenet Genomics. 2005;15:451\u20136.","key":"2025121207192862510_j_hmbci-2019-0058_ref_022_w2aab3b7c36b1b6b1ab2b1c22Aa","DOI":"10.1097\/01.fpc.0000167330.92786.5e"},{"doi-asserted-by":"crossref","unstructured":"Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002;8:893\u20139.","key":"2025121207192862510_j_hmbci-2019-0058_ref_023_w2aab3b7c36b1b6b1ab2b1c23Aa","DOI":"10.1093\/molehr\/8.10.893"},{"doi-asserted-by":"crossref","unstructured":"Valkenburg O, van Santbrink EJ, K\u00f6nig TE, Themmen AP, Uitterlinden AG, Fauser BC, et al. Follicle-stimulating hormone receptor polymorphism affects the outcome of ovulation induction in normogonadotropic (World Health Organization class 2) anovulatory subfertility. Fertil Steril. 2015;103:1081\u20131088 e3.","key":"2025121207192862510_j_hmbci-2019-0058_ref_024_w2aab3b7c36b1b6b1ab2b1c24Aa","DOI":"10.1016\/j.fertnstert.2015.01.002"},{"doi-asserted-by":"crossref","unstructured":"Greb RR, Grieshaber K, Gromoll J, Sonntag B, Nieschlag E, Kiesel L, et al. A common single nucleotide polymorphism in exon 10 of the human follicle stimulating hormone receptor is a major determinant of length and hormonal dynamics of the menstrual cycle. J Clin Endocrinol Metab. 2005;90:4866\u201372.","key":"2025121207192862510_j_hmbci-2019-0058_ref_025_w2aab3b7c36b1b6b1ab2b1c25Aa","DOI":"10.1210\/jc.2004-2268"},{"doi-asserted-by":"crossref","unstructured":"Mohiyiddeen L, Newman WG, Cerra C, McBurney H, Mulugeta B, Roberts SA, et al. A common Asn680Ser polymorphism in the follicle-stimulating hormone receptor gene is not associated with ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization. Fertil Steril. 2013;99:149\u201355.","key":"2025121207192862510_j_hmbci-2019-0058_ref_026_w2aab3b7c36b1b6b1ab2b1c26Aa","DOI":"10.1016\/j.fertnstert.2012.08.037"},{"doi-asserted-by":"crossref","unstructured":"Laven JSE. Follicle stimulating hormone receptor (FSHR) polymorphisms and polycystic ovary syndrome (PCOS). Front Endocrinol (Lausanne). 2019;10:23.","key":"2025121207192862510_j_hmbci-2019-0058_ref_027_w2aab3b7c36b1b6b1ab2b1c27Aa","DOI":"10.3389\/fendo.2019.00023"},{"doi-asserted-by":"crossref","unstructured":"Conforti A, Esteves SC, Di Rella F, Strina I, De Rosa P, Fiorenza A, et al. The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and metaanalysis. Reprod Biol Endocrinol. 2019;17:18.","key":"2025121207192862510_j_hmbci-2019-0058_ref_028_w2aab3b7c36b1b6b1ab2b1c28Aa","DOI":"10.1186\/s12958-019-0460-4"}],"container-title":["Hormone Molecular Biology and Clinical Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyter.com\/view\/journals\/hmbci\/ahead-of-print\/article-10.1515-hmbci-2019-0058\/article-10.1515-hmbci-2019-0058.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2019-0058\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2019-0058\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T08:11:07Z","timestamp":1765527067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/hmbci-2019-0058\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,2]]},"references-count":28,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,3,13]]},"published-print":{"date-parts":[[2020,7,24]]}},"alternative-id":["10.1515\/hmbci-2019-0058"],"URL":"https:\/\/doi.org\/10.1515\/hmbci-2019-0058","relation":{},"ISSN":["1868-1891","1868-1883"],"issn-type":[{"type":"electronic","value":"1868-1891"},{"type":"print","value":"1868-1883"}],"subject":[],"published":{"date-parts":[[2020,3,2]]},"article-number":"20190058"}}